IP Library › Assignment 063269/0373
Patent Assignment
Reel/Frame 063269/0373

Assignment of Assignor's Interest

Recorded: 2023-04-10 Pages: 8
Assignor
Assignee
PFIZER IRELAND PHARMACEUTICALS
OPERATIONS SUPPORT GROUP, RINGASKIDDY, COUNTY CORK, IRELAND
Covered Properties (16)
Rimegepant for Cgrp Related Disorders
Application: 16/767,134 →
Publication: US US20210000814A1
Rimegepant for Cgrp Related Disorders
Application: 16/884,196 →
Publication: US US20200383969A1
Rimegepant for Cgrp Related Disorders
Application: 17/396,717 →
Publication: US US20220168295A1
Prodrugs of Cgrp Antagonists
Application: 17/283,049 →
Publication: US US20210395223A1
Cgrp Antagonists for Treating Migraine Breakthrough
Application: 17/269,227 →
Publication: US US20210338654A1
Cgrp Antagonists for Treating Migraine Breakthrough
Application: 17/178,217 →
Publication: US US20210196699A1
Intranasal Pharmaceutical Compositions of Cgrp Inhibitors
Application: 17/769,966 →
Publication: US US20220401439A1
Oral Fast-Dispersing Dosage Form of Rimegepant
Application: 17/801,295 →
Publication: US US20230108049A1
Cell-Receptor Targeted Exosomes
Application: 17/912,450 →
Publication: US US20230149319A1
Formulation for Oral Delivery of Proteins, Peptides and Small Molecules with Poor Permeability
Application: 17/602,915 →
Publication: US US20220249468A1
Dual Treatment of Migraine
Application: 17/838,171 →
Publication: US US20230285380A1
Compositions for Improved Delivery of Cgrp Inhibitors
Pharmaceutical Compositions of Cgrp Inhibitors and Methods of Their Use
Cgrp Antagonists for Treating Psoriasis
Cgrp Antagonists for Treating Skin Conditions
Compositions for Improved Delivery of Cgrp Inhibitors
Related Assignments (11)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 5, 2020
From: BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
To: BIOHAVEN PHARMACEUTICAL IRELAND DAC
Reel/Frame 053404/0483 →
Assignment of Assignor's Interest Dec 28, 2021
From: PLASSAT, VINCENT; HILBOLD, BENOIT; GALUS, AURÉLIA; POINTEAUX, THOMAS
To: R.P. SCHERER TECHNOLOGIES, LLC
Reel/Frame 058488/0333 →
Assignment of Assignor's Interest Dec 28, 2021
From: DUBOWCHIK, GENE; CONWAY, CHARLES
To: BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
Reel/Frame 058488/0381 →
Assignment of Assignor's Interest Sep 26, 2022
From: CORIC, VLADIMIR; CHARLES M. CONWAY PH.D.; ROBERT CROOP; MARIANNE FROST
To: BIOHAVEN PHARMACEUTICAL DAC
Reel/Frame 061208/0612 →
Assignment of Assignor's Interest Sep 29, 2022
From: CORIC, VLADIMIR; CONWAY, CHARLES M., PHD; CROOP, ROBERT; KUMAR, RAJESH
To: BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
Reel/Frame 061251/0434 →
Assignment of Assignor's Interest Nov 7, 2022
From: BIOHAVEN PHARMACEUTICAL IRELAND DESIGNATED ACTIVITY COMPANY
To: PFIZER IRELAND PHARMACEUTICALS
Reel/Frame 061885/0685 →
Assignment of Assignor's Interest Nov 7, 2022
From: BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD
To: PFIZER IRELAND PHARMACEUTICALS
Reel/Frame 061885/0943 →
Assignment of Assignor's Interest Mar 15, 2023
From: KUMAR, RAJESH
To: BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
Reel/Frame 062990/0631 →
Confirmatory License Jan 10, 2024
From: BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 066266/0186 →
Security Interest Dec 19, 2024
From: CATALENT CTS (KANSAS CITY), LLC; REDWOOD BIOSCIENCE, INC.; R.P. SCHERER TECHNOLOGIES, LLC; CATALENT WELLNESS, LLC
To: ARES CAPITAL CORPORATION, AS COLLATERAL AGENT
Reel/Frame 069743/0458 →
Change of Name Jan 22, 2025
From: PFIZER IRELAND PHARMACEUTICALS
To: PFIZER IRELAND PHARMACEUTICALS UNLIMITED COMPANY
Reel/Frame 069987/0162 →